MINIPRESS PFIZER 437 (Minipress 2 mg)
Generic Name: prazosin
Pill with imprint MINIPRESS PFIZER 437 is Pink & White, Capsule-shape and has been identified as Minipress 2 mg. It is supplied by Pfizer U.S. Pharmaceuticals Group.
Minipress is used in the treatment of benign prostatic hyperplasia; high blood pressure; raynaud's syndrome; heart failure and belongs to the drug class antiadrenergic agents, peripherally acting. Risk cannot be ruled out during pregnancy. Minipress 2 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for MINIPRESS PFIZER 437
Minipress
- Generic Name:
- prazosin
- Imprint:
- MINIPRESS PFIZER 437
- Strength:
- 2 mg
- Color:
- Pink & White
- Shape:
- Capsule-shape
- Availability:
- Prescription only
- Drug Class:
- Antiadrenergic agents, peripherally acting
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- Not a controlled drug
- Labeler / Supplier:
- Pfizer U.S. Pharmaceuticals Group
- Inactive Ingredients:
- FD&C Blue No. 1
FD&C Red No. 3
D&C Red No. 28
FD&C Red No. 40
magnesium stearate
sodium lauryl sulfate
sucrose
Note: Inactive ingredients may vary.
Other Labelers / Repackagers:
| NDC Code | Labeler / Repackager |
|---|---|
| 59762-5320 | Greenstone LLC |
| 54868-1290 | Physicians Total Care Inc. (repackager) |
More about Minipress (prazosin)
- Minipress Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Images
- Drug Interactions
- Support Group
- Pricing & Coupons
- En Español
- 5 Reviews
- Generic Availability
- Drug class: antiadrenergic agents, peripherally acting
Consumer resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
